Nature Communications

TG4050 TG4050 as a single agent has the potential to prevent recurrence in head and neck cancer   Peer-reviewed publication in Nature Communications highlights the Phase 1 clinical and translational findings   Article available for the first time on Nature Communications website – Download the Article